SCHEMBL27467321

SCHEMBL27467321

CC(NC(=O)c1ccc(-c2ccccc2)cn1)C(=O)N1CCC2(CC1)CC2

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CTSA P10619 1/20 0.46
▸ USP2 O75604 4/20 0.43
▸ CYP1A2 P05177 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ DGAT1 O75907 1/20 0.43
▸ USP30 Q70CQ3 2/20 0.42
▸ HIF1A Q16665 3/20 0.42
▸ CYP3A4 P08684 3/20 0.40
▸ P2RY12 Q9H244 2/20 0.40
▸ HSD11B1 P28845 1/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ BRD4 O60885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27468379 1.00 CTSA (0.46) CTSAUSP2CYP1A2ALDH1A1HSD17B10
SCHEMBL27468378 1.00 CTSA (0.46) CTSAUSP2CYP1A2ALDH1A1HSD17B10
SCHEMBL27467218 0.87 USP2 (0.42) USP2CYP1A2ALDH1A1HSD17B10MAPK1
SCHEMBL27468247 0.87 USP2 (0.42) USP2CYP1A2ALDH1A1HSD17B10MAPK1
SCHEMBL27468310 0.86 HDAC3 (0.40) HIF1ACYP3A4P2RY12SMN1; SMN2
SCHEMBL27467222 0.86 HDAC3 (0.40) HIF1ACYP3A4P2RY12SMN1; SMN2
SCHEMBL27468312 0.86 HDAC3 (0.40) HIF1ACYP3A4P2RY12SMN1; SMN2
SCHEMBL27468442 0.85 ALDH1A1 (0.49) USP2CYP1A2ALDH1A1HSD17B10MAPK1
SCHEMBL27467376 0.85 ALDH1A1 (0.49) USP2CYP1A2ALDH1A1HSD17B10MAPK1
SCHEMBL27466907 0.82 HDAC3 (0.46) CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024108147-A1 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-05-23 — — WO disclosed
Send feedback